10 February 2021

Renewal of the CIR Certification from the Government of France

VIVEbiotech obtains the renewal of the CIR Certification from the Ministry of Higher Education, Research and Innovation of the Government of France.

Read more

10 February 2021

Authorization to manufacture investigational medicinal products

VIVEbiotech obtains authorization to manufacture investigational medicinal products.

Read more

8 February 2021

In 2021 we continue to participate in congresses

Successful participation of VIVEbiotech in three international conferences in Q1 2021.

Read more

21 January 2021

Webinar on Cell & Gene Therapy Insights

VIVEbiotech and Polyplus-transfection give a webinar on Cell & Gene Therapy Insights.

Read more

8 January 2021

VIVEbiotech collaborates with Emendo Biotherapeutics

VIVEbiotech today announces a collaboration with Emendo Biotherapeutics.

Read more

16 December 2020

VIVEbiotech winner of the 2020 Gipuzkoa SME Award

VIVEbiotech has been the winner of the 2020 Gipuzkoa SME Award which was awarded by the Spanish Chamber of Commerce and Banco Santander.

Read more

11 December 2020

Igone Bravo participates in the Industria Eguna 2020 of ADEGI

Igone Bravo, a technician in the R&D Department of VIVEbiotech, participates in the Industria Eguna 2020 of ADEGI

Read more

7 December 2020

VIVEbiotech receives a Premio Protagonistas Gipuzkoa award from Teledonosti

This past Friday, VIVEbiotech received a Premios Protagonistas Gipuzkoa award from the 2020 edition from Teledonosti. Teledonosti is a local tv station of the Gipuzkoan territory...

Read more

28 November 2020

Cristina García participates in the “MIDI Conecta” event at the University of Navarra

Cristina García, the head of the DSP Development Department at VIVEbiotech, has participated in the 6th edition of the “MIDI Conecta” event at the...

Read more

11 November 2020

VIVEbiotech successfully participates in various international meetings in 2020

VIVEbiotech has successfully participated 8 international congresses in 2020.

Read more